Phase II clinical trial of one dose of post-transplant cyclophosphamide for graft versus host disease prevention following myeloablative, peripheral blood stem cell, matched-unrelated donor transplantation

Omer Jamy, Raquel Innis-Shelton, Susan Bal, Ravi Paluri, Donna Salzman, Antonio Di Stasi, Luciano Costa, Ruby Meredith, Lawrence Lamb, Kentaro Minagawa, Shin Mineishi, Ayman Saad

Research output: Contribution to journalLetterpeer-review

4 Scopus citations
Original languageEnglish (US)
Pages (from-to)E396-E398
JournalAmerican Journal of Hematology
Issue number10
StatePublished - Oct 1 2021

All Science Journal Classification (ASJC) codes

  • Hematology

Cite this